The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $213.51

Today's change+1.10 +0.52%
Updated January 19 4:02 PM EST. Delayed by at least 15 minutes.
 

Thermo Fisher Scientific Inc

NYSE: TMO
Last

(U.S.) $213.51

Today's change+1.10 +0.52%
Updated January 19 4:02 PM EST. Delayed by at least 15 minutes.

Thermo Fisher Scientific Inc Hits New 52-week High

Thermo Fisher Scientific Inc closed up Friday by (U.S.)$1.10 or 0.52% to (U.S.)$213.51 and setting a new 52-week high. Over the last five days, shares have gained 1.59% and outperformed the S&P 500 index over the last 52 weeks with a 47.94% increase in price.

Key company metrics

  • Open(U.S.) $213.95
  • Previous close(U.S.) $212.41
  • High(U.S.) $214.57
  • Low(U.S.) $212.36
  • Bid / Ask-- / --
  • YTD % change+12.44%
  • Volume1,439,862
  • Average volume (10-day)1,628,090
  • Average volume (1-month)1,563,602
  • Average volume (3-month)1,513,415
  • 52-week range(U.S.) $140.00 to (U.S.) $214.57
  • Beta1.06
  • Trailing P/E36.27×
  • P/E 1 year forward22.82×
  • Forward PEG1.88×
  • Indicated annual dividend(U.S.) $0.60
  • Dividend yield0.28%
  • Trailing EPS(U.S.) $5.89
Updated January 19 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jul 01, 201707/01/2017Apr 01, 201704/01/2017Dec 31, 201612/31/2016
Revenue5,1164,9904,7654,953
Total other revenue--------
Total revenue5,1164,9904,7654,953
Gross profit2,3002,2832,1932,279
Total cost of revenue2,8162,7072,5732,674
Total operating expense4,4804,2394,1434,201
Selling / general / administrative1,3601,2811,3001,257
Research & development218222215213
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)86295557
Other operating expenses, total--------
Operating income636752622753
Interest income (expense), net non-operating-157-134-135-131
Gain (loss) on sale of assets--------
Other--------
Income before tax481626503652
Income after tax534612551633
Income tax, total-5313-4919
Net income534612551630
Total adjustments to net income--------
Net income before extra. items534612551633
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items534612551633
Inc. avail. to common incl. extra. items534612551630
Diluted net income534612551630
Dilution adjustment--------
Diluted weighted average shares400393394397
Diluted EPS excluding extraordinary itemsvalue per share1.341.561.401.59
Dividends per sharevalue per share0.150.150.150.15
Diluted normalized EPSvalue per share1.481.631.491.98